XML 75 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Investments (Schedule Of Fair Value Method Investments, Balance Sheets And Income Statements) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Assets                        
Cash and cash equivalents $ 11,846       $ 31,422       $ 11,846 $ 31,422 $ 34,397 $ 36,491
Net property, plant and equipment 166,545       173,556       166,545 173,556    
Patents 18,820       22,636       18,820 22,636    
Other assets 3,506       4,628       3,506 4,628    
Total assets [1] 514,870       712,668       514,870 712,668    
Liabilities and Shareholders’ Equity                        
Other noncurrent liabilities 134,000       42,000       134,000 42,000    
Equity 109,055       376,749       109,055 376,749 354,857 $ 343,780
Total liabilities and shareholders’ equity 514,870       712,668       514,870 712,668    
Revenues & Expenses:                        
Cost of goods sold                 (558,967) (641,140) (679,665)  
Income tax (expense) benefit [2]                 8,213 (13,545) (18,807)  
Net income (loss) $ 895 $ (65,213) $ 11,196 $ (22,321) $ (3,136) $ 17,133 $ 14,477 $ 19,785 $ (75,444) $ 48,259 $ 24,842  
[1] Cash and cash equivalents includes funds held in locations outside the U.S. of $9.4 million and $8.9 million at December 31, 2020 and 2019, respectively. (c)Information on exports and foreign operations are provided on the previous page. Export sales relate almost entirely to PE Films. Operations in China relate to PE Films. Operations in Brazil relate to Flexible Packaging Films.
[2] See Notes 1, 2, 3, 4 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.